Cornell’s participation in the U.S. Commerce Department initiative will help advance development and deployment of safe and trustworthy artificial intelligence technology.
Cornell AI News
News Category
Filter by Topic
Cornell, partners to supercharge NYS microchip industry
A consortium organized by Cornell and four other New York-based leaders in semiconductor research and development has been awarded $40 million by the U.S. Department of Defense to advance microelectronics innovation and manufacturing.
Consortium aims to make NYS the world’s AI capital
A consortium aiming to make New York a global leader in artificial intelligence would help Cornell play a role in shaping the future of AI, promote responsible research and development, create jobs and unlock opportunities focused on public good.
Grant to validate blood test for early breast cancer detection
Weill Cornell Medicine researchers received a $2.4 million grant from the U.S. Department of Defense Breast Cancer Research Program to evaluate a test that uses an artificial intelligence algorithm to determine whether a patient is positive for cancer.
Cornell joins new open-technology AI Alliance
Cornell has signed on as an inaugural member of the AI Alliance, an international community of researchers, developers and organizational leaders committed to supporting and enhancing open innovation in artificial intelligence.
Welcoming AI into the classroom
Students are experimenting with generative artificial intelligence in everything from essay writing to computer code creation.
AI-generated images map visual functions in the brain
Researchers have demonstrated the use of artificial-intelligence-selected natural images and AI-generated synthetic images as neuroscientific tools for probing the visual processing areas of the brain.
Researchers chart the contents of human bone marrow
A team at Weill Cornell Medicine has mapped the location and spatial features of blood-forming cells within human bone marrow, confirming hypotheses about the anatomy of this tissue and providing a powerful new means to study diseases that affect bone marrow.